Can You Buy PTP20 Peptide? What to Know Before Ordering

PTP20, also called palmitoyl tetrapeptide-20, is a biomimetic cosmetic peptide studied for hair pigmentation and gray-hair appearance. It is not an FDA-approved medication, and “research use only” sellers are not selling patient-ready treatment. Chia does not currently offer or prescribe PTP20.

What is PTP20 peptide?

PTP20 is short for palmitoyl tetrapeptide-20, a small fatty-acid-linked peptide used in cosmetic science. It is often discussed under the ingredient name Greyverse and has been studied for hair pigmentation pathways, including alpha-MSH and MC1R signaling 1.

Palmitoyl tetrapeptide-20, Greyverse, and naming basics

The name “palmitoyl” means the peptide is attached to palmitic acid, a fatty chain that can change how an ingredient behaves in topical formulas. In the sources supplied for this article, we did not identify an FDA-recognized international nonproprietary name, or INN, for PTP20 as a drug.

Greyverse is best understood as a cosmetic ingredient brand name, not proof that the ingredient is a prescription medicine. Cosmetic ingredients are regulated differently from drugs in the US, and cosmetics are not reviewed by FDA for premarket approval in the same way as new drugs 2.

How PTP20 relates to alpha-MSH and MC1R signaling

PTP20 is described in the literature as an agonist of alpha-melanocyte-stimulating hormone, or alpha-MSH. Alpha-MSH can act on the melanocortin-1 receptor, or MC1R, a receptor on melanocytes that helps regulate melanogenesis, the process of making melanin pigment 1.

This is why PTP20 appears in discussions about hair follicle pigmentation. The biology is plausible, but plausible biology is not the same as a proven clinical treatment for gray hair.

Why it is discussed for gray hair and hair pigmentation

Gray hair happens when hair follicles make less pigment or transfer less pigment into the growing hair shaft. The PTP20 paper describes pathways tied to melanin, catalase activity, hydrogen peroxide, SIRT1, and oxidative stress, all of which are discussed in gray-hair biology 1.

The important limit is this: lab and cosmetic appearance data do not prove that a peptide can permanently change a person’s natural hair color. Individual causes of graying can include age, genetics, nutritional issues, thyroid disease, autoimmune disease, and medication effects 3.

Quick facts about PTP20

PTP20 sits in the cosmetic-peptide category, not the FDA-approved peptide-drug category. The most useful way to judge it is by route of use, evidence level, product quality, and whether a licensed clinician is involved.

• What it is: palmitoyl tetrapeptide-20, a biomimetic cosmetic peptide discussed for hair pigmentation pathways 1.
• What it is not: an FDA-approved medication for gray hair, alopecia, or any disease indication.
• What evidence exists: mechanistic and cosmetic evidence, with limits; cell or follicle findings do not prove durable hair-color change in patients 1.
• What to avoid: research-use-only powders, injectable self-experimentation, oral self-dosing, and sellers that treat a certificate of analysis as a substitute for clinical safety.
• What Chia offers instead: Chia does not offer PTP20; we do offer certain clinician-reviewed longevity treatments, including GHK-Cu cream, sermorelin, NAD+, and glutathione, when clinically appropriate.

Can you buy PTP20 peptide for personal use?

You may find PTP20 online, often as a cosmetic ingredient or a research chemical. That does not mean it is safe, legal, or appropriate to use as a personal medical treatment.

Cosmetic ingredient vs research chemical vs prescription drug

A cosmetic product is meant to affect appearance, such as cleansing or beautifying. A drug is intended to diagnose, cure, mitigate, treat, or prevent disease, or to affect body structure or function in a drug-like way 2.

That line matters. A topical cosmetic serum marketed for appearance is not the same thing as a sterile injectable medication. It is also not the same as a prescription peptide drug that has gone through FDA review for a specific use.

What “for research use only” means for patients

“For research use only” means the seller is positioning the material for laboratory research, not for use in a person. Research chemical pages may list purity, solubility, molecular weight, or storage details, but those details do not establish dosing, sterility, safety, or clinical benefit for patients.

At Chia, we view this as a practical safety boundary: licensed provider evaluation and state-licensed pharmacy dispensing are very different from no-prescription research chemical shopping. That difference matters most when a product is injected, swallowed, used near mucous membranes, or used long term.

Why purity certificates do not prove clinical safety

Peptide quality can involve more than percent purity. FDA’s peptide guidance discusses issues such as impurities, immunogenicity, biological activity, and analytical methods for specific peptide drug products 4. A certificate of analysis may be useful, but it is not the same as FDA review, sterile pharmacy preparation, or clinician oversight.

Is PTP20 FDA approved?

PTP20 is not listed in FDA’s 2026 revised draft product-specific guidances for certain generic peptide products. Those guidances cover named peptide drugs such as semaglutide and tirzepatide, but they do not make every peptide sold online an FDA-approved medication 4.

FDA-approved peptide drugs vs cosmetic peptides

FDA-approved peptide drugs have specific labeled indications, manufacturing controls, and risk information. Cosmetic peptides are usually evaluated and marketed under a different framework, focused on appearance claims rather than disease treatment 2.

This is why it is misleading when online marketing blurs the line between a cosmetic peptide and a medication. A peptide can be biologically active in a lab and still not be an approved drug for patient use.

What FDA peptide guidances do and do not mean

FDA’s July 2026 peptide product-specific guidances are meant to help generic drug development and abbreviated new drug application, or ANDA, assessment for specific peptide products 4. The list includes semaglutide and tirzepatide, but not PTP20.

A guidance document is also not the same as approval of a product sold online. FDA states that guidance documents describe the agency’s current thinking and do not create binding rights for any person 5.

Why generic peptide guidance is not the same as patient approval

Generic-drug guidance is aimed at sponsors developing products that reference already approved drugs. It does not turn a cosmetic ingredient, research powder, or gray-hair serum into an FDA-approved medication for patients.

What does the evidence say about PTP20 for gray hair?

PTP20 has a real biologic rationale, but the human evidence is limited. The best current framing is “studied for hair pigmentation and gray-hair appearance,” not “proven to reverse gray hair.”

Cell and follicle evidence: melanin, catalase, and oxidative stress

The PTP20 literature describes effects on melanocyte and hair-follicle pathways, including melanin-related signaling, catalase activity, hydrogen peroxide reduction, and SIRT1 activity 1. These are relevant because oxidative stress and pigment-cell function are part of the biology of hair graying.

But cell and follicle models are early evidence. They help explain a possible mechanism; they do not prove that a topical product will change hair color for every person or that any effect will last.

Human cosmetic evidence: what can and cannot be concluded

Cosmetic peptide studies can measure appearance changes, user assessments, imaging, or hair-fiber findings. Those outcomes may be useful for product development, but they are not the same as treating a medical disease.

Open-label cosmetic studies also have limits because participants and researchers know what is being used. In cosmetic peptide research, open-label designs can suggest a signal, but they do not provide the same confidence as randomized, blinded, controlled trials 6.

Evidence limits: appearance outcomes are not the same as disease treatment

Gray-hair appearance is not always a disease. If a product changes shine, contrast, scalp condition, or visible tone, people may perceive less gray even if follicle pigment biology has not permanently changed.

For that reason, we would not describe PTP20 as a treatment, cure, or reversal for gray hair. A more accurate statement is that it has been investigated for cosmetic hair-pigmentation appearance, with uncertain durability and limited clinical proof.

What safety questions should you ask before using PTP20?

PTP20 safety depends heavily on the product, route, concentration, quality controls, and your skin or medical history. The biggest red flag is any seller or forum suggesting injection or oral self-experimentation without medical oversight.

Skin irritation, allergy, and product quality concerns

Topical products can irritate the scalp or skin, especially if they include fragrance, alcohols, preservatives, or multiple active ingredients. FDA notes that cosmetic products and ingredients, other than color additives, generally do not need FDA approval before they go on the market 2.

If you have eczema, scalp psoriasis, alopecia areata, sudden shedding, patchy hair loss, or a history of allergic reactions, it is safer to talk with a clinician before trying new scalp actives. Hair and scalp symptoms can have medical causes that cosmetics will not address 3.

Why injectable or oral self-experimentation is not supported

We do not recommend injecting, swallowing, or self-compounding PTP20. The supplied evidence does not establish patient dosing, sterility, systemic safety, or benefit for those routes.

This is not just a paperwork issue. Peptide products can raise complex questions about impurities, immune response, activity, and quality testing, which is why FDA guidance for actual peptide drugs goes into detailed analytical expectations 4.

When to talk with a licensed clinician or dermatologist

Talk with a clinician if hair color changes are sudden, patchy, linked with hair loss, or paired with fatigue, weight change, rash, scalp pain, or new medications. A clinician may consider common contributors such as thyroid disease, nutritional deficiency, autoimmune hair loss, inflammation, or medication effects 3.

Does Chia offer PTP20 or prescribe it online?

PTP20 is not currently in Chia’s treatment catalog. We do not offer PTP20 tablets, injections, creams, sprays, compounded formulations, or prescriptions.

Chia does not currently offer PTP20

If your main question is “Can I buy PTP20 through Chia?” the answer is no. This article is here to help you understand the evidence and safety issues before ordering from a research-chemical or cosmetic seller.

What Chia does offer in peptides and longevity treatments

Chia does offer several clinician-reviewed longevity and peptide-adjacent treatments when appropriate, including GHK-Cu cream, sermorelin injection, nasal spray, or tablets, NAD+ injection or nasal spray, and glutathione injection or nasal spray. These are separate treatments with different goals, evidence limits, safety questions, and routes of use.

For example, GHK-Cu is a copper peptide used in skin-focused care 9, while sermorelin is a growth-hormone-releasing hormone analog used in selected longevity protocols 10. Neither should be treated as a substitute for PTP20, and neither is a proven gray-hair reversal treatment.

How clinician review works for treatments that are in Chia’s catalog

For treatments Chia does offer, the process is 100% online: a short health questionnaire, review by a licensed US provider, provider-guided dosing when prescribed, and pharmacy shipment to your door where clinically appropriate. A prescription is never guaranteed.

Chia’s available protocols include Foundation Longevity, Glow, and Weight + Muscle. These protocols use treatments listed in our current catalog; they do not include PTP20.

How does PTP20 compare with other peptide products people search for?

PTP20 is best compared by route, intended use, and evidence level. A topical cosmetic peptide, a compounded prescription treatment, an FDA-approved peptide drug, and a research-use-only powder are not interchangeable.

PTP20 vs GHK-Cu

PTP20 is discussed for MC1R and hair-pigment signaling. GHK-Cu is a copper-binding peptide more often discussed for skin quality and repair pathways 9; at Chia, GHK-Cu is available as a cream when appropriate.

PTP20 vs sermorelin

Sermorelin acts on the growth-hormone axis 10 and is not a hair-pigmentation peptide. Chia offers sermorelin as injection, nasal spray, and tablets, with licensed-provider review and provider-guided dosing where prescribed.

PTP20 vs FDA-approved peptide medications

FDA-approved peptide medications have labeled indications and product-specific review. FDA’s 2026 peptide PSG update includes products such as semaglutide and tirzepatide, but this does not apply to PTP20 4.

Why route of use and evidence level matter

A topical cosmetic ingredient has different risks from an injectable product. The more invasive the route, the more quality, sterility, dosing, and monitoring matter.

What should you do if your goal is gray-hair or hair-health treatment?

If your goal is gray hair or hair health, start with the cause rather than a peptide shopping list. Cosmetic products may be reasonable for appearance goals, but sudden hair changes or hair loss deserve medical evaluation.

Start with the cause

Hair graying is strongly influenced by aging and genetics. Hair changes can also be linked with thyroid disease, nutritional deficiency, autoimmune conditions, inflammatory scalp disease, stress, and medication effects 3.

If your hair change is sudden, patchy, painful, or linked with shedding, a dermatologist or primary care clinician can help decide whether labs, scalp exam, or treatment are needed.

When cosmetic products may be reasonable

Cosmetic products may be reasonable if your goal is appearance and you understand the limits. Look for clear ingredient lists, realistic claims, patch testing instructions, and avoidance of disease-treatment promises.

When medical evaluation is more appropriate

Medical evaluation is more appropriate when hair changes come with shedding, scalp symptoms, eyebrow loss, fatigue, unexplained weight change, menstrual changes, rash, or new medication exposure. Those clues can point to causes that a cosmetic peptide will not address.

Keep reading

Peptides

Can You Buy Cartalax Peptide? What Patients Should Know First

Peptides

Can You Buy PGPIPN Peptide? Evidence, Safety, and Safer Access Options

Peptides

N-Acetyl Selank Peptide: What It Is, What the Evidence Shows, and Safety Limits